Love Pharma Inc (TSE:JOLT) has released an update.
Jolt Health Inc. is actively expanding its health and wellness portfolio, with a particular focus on AI drug development and the pharmaceutical sector, aiming to address various health concerns and capitalize on a burgeoning market. The company has also announced a private placement financing to raise up to $500,000, as well as board changes with Cody Corrubia joining and Mark Tommasi resigning.
For further insights into TSE:JOLT stock, check out TipRanks’ Stock Analysis page.
